Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.PGEN · Entity 4356 | Chief Financial Officer | September 23, 2026 | September 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date September 23, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 311,914 |
Ending reported balance
After 2026-09-23 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-23 · Exercise / conversion · Acquired 10,744 · Balance 268,993 Row 2 · 2026-09-23 · Exercise / conversion · Acquired 42,918 · Balance 311,911 Row 3 · 2026-09-23 · Exercise / conversion · Acquired 2 · Balance 311,913 Row 4 · 2026-09-23 · Exercise / conversion · Acquired 1 · Balance 311,914 |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.72 · Expires 2031-10-18 | Direct | 169,256 |
Reported balance
After 2026-09-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-23 · Exercise / conversion · Disposed 10,744 · Balance 169,256 F1: The options are fully vested. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.33 · Expires 2032-02-02 | Direct | 157,082 |
Reported balance
After 2026-09-23 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-23 · Exercise / conversion · Disposed 42,918 · Balance 157,082 F1: The options are fully vested. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.96 · Expires 2033-03-24 | Direct | 46,813 |
Reported balance
After 2026-09-23 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-23 · Exercise / conversion · Disposed 2 · Balance 46,813 F1: The options are fully vested. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.21 · Expires 2033-04-28 | Direct | 520,999 |
Reported balance
After 2026-09-23 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-23 · Exercise / conversion · Disposed 1 · Balance 520,999 F2: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The options are fully vested.
F2: The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 46,815 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · derivative · entry 4 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,815 Underlying: Common Stock · 46,815 shares Expires 2033-03-24 Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 35,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · derivative · entry 3 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,737 Underlying: Common Stock · 35,868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. F3 · derivative.expiration_date: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 107,605 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · derivative · entry 2 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,605 Underlying: Common Stock · 107,605 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. F2 · derivative.expiration_date: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023. Read SEC document |
| March 24, 2023 Filed Mar 29, 2023 01:12 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 35,868 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-004828 · dp191374_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 00:19 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 28,571 | $1.75 | $49,999.25 |
DisclosureSEC source: 0000950103-23-001412 · dp187979_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,961 F1 · kind: The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price. Read SEC document |
| August 23, 2022 Filed Aug 24, 2022 20:58 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 24,500 | $2.09 | $51,205.00 |
DisclosureSEC source: 0000950103-22-014410 · dp179123_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,390 Read SEC document |
| May 17, 2022 Filed May 18, 2022 22:51 UTC | PRECIGEN, INC. PGEN · Entity 4356 | SaleCommon Stock | 2,719 | $1.28 | $3,480.32 |
DisclosureSEC source: 0000950103-22-008789 · dp173454_4-thomasian.xml · nonDerivative · entry 2 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,890 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:51 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 8,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-008789 · dp173454_4-thomasian.xml · derivative · entry 3 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs were granted on March 18, 2022 and have vested in full. F3 · derivative.expiration_date: The RSUs were granted on March 18, 2022 and have vested in full. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:51 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 8,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-22-008789 · dp173454_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 21:01 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 8,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-005049 · dp169632_4-thomasian.xml · derivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,109 Underlying: Common Stock · 8,109 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vest in full on May 16, 2022. F2 · derivative.expiration_date: The RSUs vest in full on May 16, 2022. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:11 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.33 | $0.00 |
DisclosureSEC source: 0000950103-22-002083 · dp166689_4-thomasian.xml · derivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-02 F1 · derivative.exercise_date: The option vests in four equal installments on each of February 2, 2023, February 2, 2024, February 2, 2025 and February 2, 2026. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 22:04 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 13,400 | $3.80 | $50,920.00 |
DisclosureSEC source: 0000950103-21-018848 · dp162763_4-thomasian.xml · nonDerivative · entry 2 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,500 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 22:04 UTC | PRECIGEN, INC. PGEN · Entity 4356 | PurchaseCommon Stock | 13,100 | $3.81 | $49,911.00 |
DisclosureSEC source: 0000950103-21-018848 · dp162763_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 20:48 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0000950103-21-016165 · dp160061_4-thomasian.xml · derivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2031-10-18 F1 · derivative.exercise_date: The option vests in four equal installments on each of October 18, 2022, October 18, 2023, October 18, 2024 and October 18, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.